Delivery Order SPE2DB22D2211-SPE2DB24FRHQA

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,372.95 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,590,859 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $7,648.67 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of essential...
The U.S. Defense Logistics Agency (DLA) awarded a $5,454.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support...
The Defense Logistics Agency (DLA) awarded a $20,264.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government...
The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,376.12 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of medical commodities to support military treatment programs...
This is a $9,940.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a period of performance through July 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.97 firm fixed price delivery order is for the supply of FLUTICASONE-SALMETEROL 115-21 12GM, a medication, with a completion date of June 12, 2025. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,841.64 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide fluticasone-salmeterol 115-21 12GM medical products. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a wide range of pharmaceutical and medical supplies to...
This is a $31,988.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE-SALMETEROL 230-21 12GM. The contract has an ultimate completion date of June 4, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $16,871.42 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the procurement of the pharmaceutical product Fluticasone-Salmeterol 230-21 12GM. The contract has a Firm Fixed Price pricing type and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FRHQA
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,273.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, Fluticasone-Salmeterol 115-21 12GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of September 18, 2024 and does not utilize a set-aside designation.

Generated 12/17/24, 9:12 AM